NATHANIEL A RATNASAMY
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease
- Where
- FINDLAY, OH
- NPI
- 1558363317
- Received
- $254,655 in 178 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 53 | $37,155 |
| 2024 | General payment | 43 | $41,245 |
| 2023 | General payment | 24 | $26,281 |
| 2022 | General payment | 14 | $37,844 |
| 2021 | General payment | 12 | $37,600 |
| 2020 | General payment | 16 | $37,937 |
| 2019 | General payment | 16 | $36,589 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 71 | $216,465 | 2020–2025 |
| Shire North American Group Inc | 12 | $36,400 | 2019 |
| Gilead Sciences, Inc. | 30 | $425 | 2019–2025 |
| ViiV Healthcare Company | 32 | $377 | 2022–2025 |
| ABBVIE INC. | 13 | $215 | 2022–2025 |
| Insmed, Inc. | 3 | $138 | 2019–2025 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 | 2024 |
| Dexcom, Inc. | 1 | $95 | 2025 |
| Merck Sharp & Dohme LLC | 5 | $92 | 2024–2025 |
| E.R. Squibb & Sons, L.L.C. | 2 | $81 | 2023–2024 |
| Aimmune Therapeutics, Inc. | 3 | $49 | 2024–2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $48 | 2023 |
| AstraZeneca Pharmaceuticals LP | 1 | $47 | 2020 |
| Janssen Pharmaceuticals, Inc | 1 | $40 | 2019 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 | 2019 |
| PFIZER INC. | 1 | $14 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 81 | $252,681 |
| Food and Beverage | 94 | $1,691 |
| Travel and Lodging | 2 | $183 |
| Education | 1 | $99 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-11 | ViiV Healthcare Company | $8 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-11-05 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-10-23 | Aimmune Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | VOWST Biological, GI | 2025 | |
| 2025-10-16 | Gilead Sciences, Inc. | $11 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-16 | Gilead Sciences, Inc. | $2 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-10 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-10-09 | Gilead Sciences, Inc. | $9 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-08 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-01 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-24 | Insmed, Inc. | $18 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-09-23 | ViiV Healthcare Company | $30 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-09-10 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-08-26 | Gilead Sciences, Inc. | $8 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-25 | ViiV Healthcare Company | $12 | Food and Beverage | In-kind items and services | APRETUDE Drug, HIV | 2025 | |
| 2025-08-21 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | AVYCAZ Drug, ANTI-INFECTIVE | 2025 | |
| 2025-08-21 | Gilead Sciences, Inc. | $11 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-20 | ViiV Healthcare Company | $1 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-08-13 | ViiV Healthcare Company | $9 | Food and Beverage | In-kind items and services | RUKOBIA Drug, HIV | 2025 | |
| 2025-08-08 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-08-04 | ViiV Healthcare Company | $4 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-07-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-10 | ViiV Healthcare Company | $6 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-07-08 | Gilead Sciences, Inc. | $18 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-08 | Gilead Sciences, Inc. | $2 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-30 | ViiV Healthcare Company | $17 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-06-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-06-08 | ViiV Healthcare Company | $2 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-05-21 | Merck Sharp & Dohme LLC | $13 | Food and Beverage | In-kind items and services | VAQTA Biological, VACCINE | 2025 | |
| 2025-05-19 | Gilead Sciences, Inc. | $1 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-28 | ViiV Healthcare Company | $14 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-04-28 | Gilead Sciences, Inc. | $1 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-03 | Gilead Sciences, Inc. | $11 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-01 | Gilead Sciences, Inc. | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-31 | Dexcom, Inc. | $95 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2025 | |
| 2025-03-28 | ViiV Healthcare Company | $7 | Food and Beverage | In-kind items and services | RUKOBIA Drug, HIV | 2025 | |
| 2025-03-25 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | PREVNAR 20 Biological, VACCINES | 2025 | |
| 2025-03-12 | Takeda Pharmaceuticals U.S.A., Inc. | $3,350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-09 | ViiV Healthcare Company | $3 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-03-09 | ViiV Healthcare Company | $1 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-02-17 | Gilead Sciences, Inc. | $2 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-12 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-12 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-11 | Gilead Sciences, Inc. | $2 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-03 | ViiV Healthcare Company | $6 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2025-01-28 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | AVYCAZ Drug, ANTI-INFECTIVE | 2025 | |
| 2025-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-01-14 | Gilead Sciences, Inc. | $6 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-14 | Gilead Sciences, Inc. | $3 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-14 | Gilead Sciences, Inc. | $1 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-09 | ViiV Healthcare Company | $11 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2025 | |
| 2024-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-09 | Insmed, Inc. | $21 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2024 | |
| 2024-12-03 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | PIFELTRO Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-11-13 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-12 | ViiV Healthcare Company | $13 | Food and Beverage | In-kind items and services | RUKOBIA Drug, HIV | 2024 | |
| 2024-11-04 | Takeda Pharmaceuticals U.S.A., Inc. | $1,625 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-10-21 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-10-14 | ViiV Healthcare Company | $33 | Food and Beverage | In-kind items and services | APRETUDE Biological, HIV | 2024 | |
| 2024-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-10-02 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | AVYCAZ Drug, ANTI-INFECTIVE | 2024 | |
| 2024-10-02 | ViiV Healthcare Company | $17 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-09-16 | Gilead Sciences, Inc. | $22 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-14 | ViiV Healthcare Company | $4 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-09-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-09-10 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | DELSTRIGO Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-08-29 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | TEFLARO Drug, ANTI-INFECTIVE | 2024 | |
| 2024-08-26 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-08-21 | Gilead Sciences, Inc. | $25 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-14 | ViiV Healthcare Company | $5 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-08-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-08-05 | ViiV Healthcare Company | $21 | Food and Beverage | In-kind items and services | RUKOBIA Drug, HIV | 2024 | |
| 2024-07-23 | ViiV Healthcare Company | $2 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-07-18 | Aimmune Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | VOWST Biological, GI | 2024 | |
| 2024-07-12 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-06-11 | ViiV Healthcare Company | $14 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-06-10 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-06-04 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | PIFELTRO Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-06-03 | Aimmune Therapeutics, Inc. | $13 | Food and Beverage | In-kind items and services | VOWST Biological, GI | 2024 | |
| 2024-05-22 | ViiV Healthcare Company | $5 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-05-21 | E.R. Squibb & Sons, L.L.C. | $42 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-05-20 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-05-10 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-05-02 | ViiV Healthcare Company | $20 | Food and Beverage | In-kind items and services | RUKOBIA Drug, HIV | 2024 | |
| 2024-04-17 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-04-17 | ViiV Healthcare Company | $6 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-04-16 | Alexion Pharmaceuticals, Inc. | $125 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-03-28 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-02-28 | Gilead Sciences, Inc. | $17 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-14 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-02-06 | ViiV Healthcare Company | $16 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2024 | |
| 2024-01-30 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | AVYCAZ Drug, ANTI-INFECTIVE | 2024 | |
| 2024-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2023-12-15 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-12-12 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-14 | Gilead Sciences, Inc. | $10 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-10 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-10-03 | ViiV Healthcare Company | $18 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2023 | |
| 2023-09-13 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-09-01 | Gilead Sciences, Inc. | $3 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-07-25 | ViiV Healthcare Company | $13 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2023 | |
| 2023-07-18 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-07-14 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-06-14 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-06-14 | Gilead Sciences, Inc. | $2 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $48 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-04-25 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | AVYCAZ Drug, ANTI-INFECTIVE | 2023 | |
| 2023-04-07 | Takeda Pharmaceuticals U.S.A., Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-03-28 | Gilead Sciences, Inc. | $124 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2023 | |
| 2023-03-14 | Gilead Sciences, Inc. | $13 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-03-07 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-02-28 | ViiV Healthcare Company | $13 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2023 | |
| 2023-02-21 | E.R. Squibb & Sons, L.L.C. | $38 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2023 | |
| 2023-02-08 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-02-06 | ViiV Healthcare Company | $18 | Food and Beverage | In-kind items and services | APRETUDE Biological, HIV | 2023 | |
| 2023-01-09 | Gilead Sciences, Inc. | $15 | Food and Beverage | In-kind items and services | 2023 | ||
| 2022-12-07 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-11-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-10-24 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2022 | |
| 2022-10-05 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-09-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-08-17 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-08-09 | ViiV Healthcare Company | $12 | Food and Beverage | In-kind items and services | DOVATO Drug, HIV | 2022 | |
| 2022-07-13 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-06-06 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-05-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-04-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-03-08 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-02-07 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-01-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2021-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-11-06 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-10-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-09-13 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-08-10 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-07-15 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-06-10 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-05-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-04-12 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-03-08 | Takeda Pharmaceuticals U.S.A., Inc. | $3,150 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-02-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-01-12 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2020-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-11-10 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-09-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-09-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-06-24 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-06-08 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-05-06 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-04-13 | Takeda Pharmaceuticals U.S.A., Inc. | $90 | Travel and Lodging | In-kind items and services | 2020 | ||
| 2020-04-07 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-03-04 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-02-18 | AstraZeneca Pharmaceuticals LP | $47 | Food and Beverage | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | 2020 | |
| 2020-02-06 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $1,106 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $92 | Travel and Lodging | In-kind items and services | 2020 | ||
| 2020-01-06 | Takeda Pharmaceuticals U.S.A., Inc. | $3,050 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2019-12-05 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-11-20 | Regeneron Healthcare Solutions, Inc. | $37 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-11-06 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-10-07 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-09-04 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-08-07 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-07-03 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-06-06 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-05-20 | Gilead Sciences, Inc. | $13 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-05-09 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-04-18 | Insmed, Inc. | $99 | Education | In-kind items and services | Arikayce Drug, Respiratory | 2019 | |
| 2019-04-17 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-03-13 | Shire North American Group Inc | $3,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-02-19 | Janssen Pharmaceuticals, Inc | $40 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-02-13 | Shire North American Group Inc | $2,950 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-01-04 | Shire North American Group Inc | $2,950 | Consulting Fee | Cash or cash equivalent | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Findlay, OH, county Hancock County, OH, state Ohio; placed by its city name.
| Measure | Place (city or town) Findlay, OH | County Hancock County, OH | State Ohio |
|---|---|---|---|
| Population B01003 | 40,287 | 74,866 | 11,810,293 |
| Population, 2020 census P1 | 40,313 | 74,920 | 11,799,448 |
| Median age B01002 | 38.0 | 39.5 | 39.7 |
| Under 18 B01001 | 19.9% | 21.8% | 22.0% |
| 65 and over B01001 | 19.2% | 18.6% | 18.3% |
| Households B11001 | 17,986 | 31,615 | 4,863,191 |
| Foreign born B05002 | 4.3% | 3.3% | 5.2% |
| Median household income B19013 | $61,423 | $73,141 | $71,389 |
| Median family income B19113 | $82,878 | $91,870 | $92,749 |
| Per capita income B19301 | $37,029 | $39,068 | $40,552 |
| Poverty rate B17001 | 12.3% | 9.9% | 13.3% |
| Unemployment rate B23025 | 3.5% | 3.1% | 4.8% |
| Civilian labor force B23025 | 20,835 | 38,730 | 5,994,779 |
| Mean commute (minutes) B08013 | 16.1 | 18.0 | 23.4 |
| Bachelor's degree or higher B15003 | 30.6% | 30.3% | 31.5% |
| Housing units B25001 | 19,200 | 33,920 | 5,292,391 |
| Owner-occupied B25003 | 59.9% | 70.8% | 67.2% |
| Renters B25003 | 40.1% | 29.2% | 32.8% |
| Median home value B25077 | $191,000 | $204,700 | $214,800 |
| Median gross rent B25064 | $975 | $979 | $1,034 |
| White, not Hispanic B03002 | 82.8% | 86.9% | 75.8% |
| Black B03002 | 2.6% | 1.8% | 12.0% |
| Hispanic or Latino B03002 | 8.5% | 6.1% | 4.8% |
| Asian B03002 | 2.2% | 1.9% | 2.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Findlay, OH.
Comments